India's Vivo Biotech Signs MOU With Malaysia To Make Tropical Vaccines
This article was originally published in PharmAsia News
Executive Summary
Vivo Biotech India has signed a memorandum of understanding in Malaysia to open a $150 million facility to make vaccines to guard against tropical illnesses